Back to Search
Start Over
Staphylococcus aureus alpha-toxin inhibits CD8 + T cell-mediated killing of cancer cells in cutaneous T-cell lymphoma.
- Source :
-
Oncoimmunology [Oncoimmunology] 2020 Apr 17; Vol. 9 (1), pp. 1751561. Date of Electronic Publication: 2020 Apr 17 (Print Publication: 2020). - Publication Year :
- 2020
-
Abstract
- Staphylococcus aureus and its toxins have been linked to disease progression and mortality in advanced stages of cutaneous T-cell lymphoma (CTCL). CD8 <superscript>+</superscript> T cells play a crucial role in anti-cancer responses and high CD8 <superscript>+</superscript> T cell numbers in tumor lesions are associated with a favorable prognosis in CTCL. Here, we show that CD8 <superscript>+</superscript> T cells from both healthy donors and Sézary syndrome patients are highly susceptible to cell death induced by Staphylococcal alpha-toxin, whereas malignant T cells are not. Importantly, alpha-toxin almost completely blocks cytotoxic killing of CTCL tumor cells by peptide-specific CD8 <superscript>+</superscript> T cells, leading to their escape from induced cell death and continued proliferation. These findings suggest that alpha-toxin may favor the persistence of malignant CTCL cells in vivo by inhibiting CD8 <superscript>+</superscript> T cell cytotoxicity. Thus, we propose a novel mechanism by which colonization with Staphylococcus aureus may contribute to cancer immune evasion and disease progression in CTCL.<br /> (© 2020 The Author(s). Published with license by Taylor & Francis Group, LLC.)
Details
- Language :
- English
- ISSN :
- 2162-4011
- Volume :
- 9
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Oncoimmunology
- Publication Type :
- Academic Journal
- Accession number :
- 32363124
- Full Text :
- https://doi.org/10.1080/2162402X.2020.1751561